These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
216 related articles for article (PubMed ID: 31956272)
1. Amino acid transporters as tetraspanin TM4SF5 binding partners. Jung JW; Kim JE; Kim E; Lee JW Exp Mol Med; 2020 Jan; 52(1):7-14. PubMed ID: 31956272 [TBL] [Abstract][Full Text] [Related]
2. Correlations between transmembrane 4 L6 family member 5 (TM4SF5), CD151, and CD63 in liver fibrotic phenotypes and hepatic migration and invasive capacities. Kang M; Ryu J; Lee D; Lee MS; Kim HJ; Nam SH; Song HE; Choi J; Lee GH; Kim TY; Lee H; Kim SJ; Ye SK; Kim S; Lee JW PLoS One; 2014; 9(7):e102817. PubMed ID: 25033048 [TBL] [Abstract][Full Text] [Related]
3. TM4SF5-Mediated Roles in the Development of Fibrotic Phenotypes. Ryu J; Lee JW Mediators Inflamm; 2017; 2017():5108525. PubMed ID: 28458469 [TBL] [Abstract][Full Text] [Related]
4. Dynamic and coordinated single-molecular interactions at TM4SF5-enriched microdomains guide invasive behaviors in 2- and 3-dimensional environments. Kim HJ; Kwon S; Nam SH; Jung JW; Kang M; Ryu J; Kim JE; Cheong JG; Cho CY; Kim S; Song DG; Kim YN; Kim TY; Jung MK; Lee KM; Pack CG; Lee JW FASEB J; 2017 Apr; 31(4):1461-1481. PubMed ID: 28073834 [TBL] [Abstract][Full Text] [Related]
6. Bidirectional signaling between TM4SF5 and IGF1R promotes resistance to EGFR kinase inhibitors. Choi J; Kang M; Nam SH; Lee GH; Kim HJ; Ryu J; Cheong JG; Jung JW; Kim TY; Lee HY; Lee JW Lung Cancer; 2015 Oct; 90(1):22-31. PubMed ID: 26190015 [TBL] [Abstract][Full Text] [Related]
7. TM4SF5-Mediated Regulation of Hepatocyte Transporters during Metabolic Liver Diseases. Kim JE; Kim E; Lee JW Int J Mol Sci; 2022 Jul; 23(15):. PubMed ID: 35955521 [TBL] [Abstract][Full Text] [Related]
8. Antagonistic regulation of transmembrane 4 L6 family member 5 attenuates fibrotic phenotypes in CCl(4) -treated mice. Kang M; Jeong SJ; Park SY; Lee HJ; Kim HJ; Park KH; Ye SK; Kim SH; Lee JW FEBS J; 2012 Feb; 279(4):625-35. PubMed ID: 22177033 [TBL] [Abstract][Full Text] [Related]
9. Transmembrane 4 L Six Family Member 5 (TM4SF5)-Mediated Epithelial-Mesenchymal Transition in Liver Diseases. Lee JW Int Rev Cell Mol Biol; 2015; 319():141-63. PubMed ID: 26404468 [TBL] [Abstract][Full Text] [Related]
10. Glucose-mediated mitochondrial reprogramming by cholesterol export at TM4SF5-enriched mitochondria-lysosome contact sites. Kim JE; Park SY; Kwak C; Lee Y; Song DG; Jung JW; Lee H; Shin EA; Pinanga Y; Pyo KH; Lee EH; Kim W; Kim S; Jun CD; Yun J; Choi S; Rhee HW; Liu KH; Lee JW Cancer Commun (Lond); 2024 Jan; 44(1):47-75. PubMed ID: 38133457 [TBL] [Abstract][Full Text] [Related]
11. Transmembrane 4 L Six Family Member 5 Senses Arginine for mTORC1 Signaling. Jung JW; Macalino SJY; Cui M; Kim JE; Kim HJ; Song DG; Nam SH; Kim S; Choi S; Lee JW Cell Metab; 2019 Jun; 29(6):1306-1319.e7. PubMed ID: 30956113 [TBL] [Abstract][Full Text] [Related]
12. Tetraspanin TM4SF5 in hepatocytes negatively modulates SLC27A transporters during acute fatty acid supply. Park D; Kim E; Lee H; Shin EA; Lee H; Lee JW Arch Biochem Biophys; 2021 Oct; 710():109004. PubMed ID: 34364885 [TBL] [Abstract][Full Text] [Related]
13. Crosstalk between TM4SF5 and GLUT8 regulates fructose metabolism in hepatic steatosis. Lee H; Kim E; Shin EA; Shon JC; Sun H; Kim JE; Jung JW; Lee H; Pinanga Y; Song DG; Liu KH; Lee JW Mol Metab; 2022 Apr; 58():101451. PubMed ID: 35123128 [TBL] [Abstract][Full Text] [Related]
14. The extracellular loop 2 of TM4SF5 inhibits integrin alpha2 on hepatocytes under collagen type I environment. Lee SA; Kim YM; Kwak TK; Kim HJ; Kim S; Ko W; Kim SH; Park KH; Kim HJ; Cho M; Lee JW Carcinogenesis; 2009 Nov; 30(11):1872-9. PubMed ID: 19789264 [TBL] [Abstract][Full Text] [Related]
15. Tetraspanin TM4SF5 mediates loss of contact inhibition through epithelial-mesenchymal transition in human hepatocarcinoma. Lee SA; Lee SY; Cho IH; Oh MA; Kang ES; Kim YB; Seo WD; Choi S; Nam JO; Tamamori-Adachi M; Kitajima S; Ye SK; Kim S; Hwang YJ; Kim IS; Park KH; Lee JW J Clin Invest; 2008 Apr; 118(4):1354-66. PubMed ID: 18357344 [TBL] [Abstract][Full Text] [Related]
16. Tetraspan TM4SF5-dependent direct activation of FAK and metastatic potential of hepatocarcinoma cells. Jung O; Choi S; Jang SB; Lee SA; Lim ST; Choi YJ; Kim HJ; Kim DH; Kwak TK; Kim H; Kang M; Lee MS; Park SY; Ryu J; Jeong D; Cheong HK; Kim HJ; Park KH; Lee BJ; Schlaepfer DD; Lee JW J Cell Sci; 2012 Dec; 125(Pt 24):5960-73. PubMed ID: 23077174 [TBL] [Abstract][Full Text] [Related]
17. Cross-talk between TGFβ1 and EGFR signalling pathways induces TM4SF5 expression and epithelial-mesenchymal transition. Kang M; Choi S; Jeong SJ; Lee SA; Kwak TK; Kim H; Jung O; Lee MS; Ko Y; Ryu J; Choi YJ; Jeong D; Lee HJ; Ye SK; Kim SH; Lee JW Biochem J; 2012 May; 443(3):691-700. PubMed ID: 22292774 [TBL] [Abstract][Full Text] [Related]
18. Modulation of signaling between TM4SF5 and integrins in tumor microenvironment. Lee SA; Park KH; Lee JW Front Biosci (Landmark Ed); 2011 Jan; 16(5):1752-8. PubMed ID: 21196261 [TBL] [Abstract][Full Text] [Related]
19. TM4SF5-mediated liver malignancy involves NK cell exhaustion-like phenotypes. Sun H; Kim E; Ryu J; Lee H; Shin EA; Lee M; Lee H; Lee JH; Yoon JH; Song DG; Kim S; Lee JW Cell Mol Life Sci; 2021 Dec; 79(1):49. PubMed ID: 34921636 [TBL] [Abstract][Full Text] [Related]
20. Liver-originated small extracellular vesicles with TM4SF5 target brown adipose tissue for homeostatic glucose clearance. Jung JW; Kim JE; Kim E; Lee H; Lee H; Shin EA; Lee JW J Extracell Vesicles; 2022 Sep; 11(9):e12262. PubMed ID: 36063136 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]